| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,109 |
2,050 |
$1.29M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,382 |
1,335 |
$459K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
364 |
352 |
$287K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,629 |
2,787 |
$126K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,855 |
1,802 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,221 |
2,859 |
$34K |
| 80053 |
Comprehensive metabolic panel |
2,262 |
2,029 |
$33K |
| 87070 |
|
1,427 |
1,379 |
$27K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
508 |
392 |
$25K |
| 81002 |
|
3,648 |
2,373 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
768 |
500 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
3,959 |
3,316 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
782 |
588 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
67 |
67 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
313 |
234 |
$8K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
59 |
51 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
210 |
205 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
191 |
188 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
111 |
109 |
$7K |
| 84436 |
|
206 |
201 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
102 |
102 |
$5K |
| 80306 |
|
162 |
155 |
$4K |
| 81001 |
|
933 |
872 |
$3K |
| 99460 |
|
42 |
41 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$2K |
| 86701 |
|
154 |
150 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
14 |
13 |
$2K |
| 87634 |
|
15 |
15 |
$2K |
| 99462 |
|
41 |
30 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
45 |
44 |
$1K |
| 87807 |
|
52 |
49 |
$957.10 |
| 80061 |
Lipid panel |
67 |
66 |
$940.42 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16 |
12 |
$667.95 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
13 |
$647.39 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
13 |
$636.35 |
| 81025 |
|
40 |
37 |
$594.65 |
| 87186 |
|
37 |
33 |
$552.44 |
| 87077 |
|
32 |
32 |
$419.30 |
| 85730 |
|
28 |
28 |
$326.51 |
| T1015 |
Clinic visit/encounter, all-inclusive |
12 |
12 |
$316.38 |
| 83655 |
|
12 |
12 |
$280.09 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
25 |
$244.31 |
| 85610 |
|
28 |
28 |
$235.49 |
| 84703 |
|
28 |
26 |
$205.64 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$93.84 |
| 86140 |
|
12 |
12 |
$75.22 |